Capitalization |
12 Months Ended |
|---|---|
Mar. 31, 2026 | |
| Equity [Abstract] | |
| Capitalization | Capitalization Common Stock We have 41,255 and 44,104 shares of common stock, par value $0.01, outstanding at March 31, 2026 and March 31, 2025, respectively. During fiscal 2026, the Board approved recommitments of our existing share repurchase program, each making $250,000 available. The share repurchase program has no expiration date. We repurchased $446,106 of our common stock during fiscal 2026, or approximately 4,173 shares, of which $117,660, or approximately 658 shares, was made in connection with the Notes. The shares repurchased during the period were funded primarily from the net proceeds received from the issuance of the Notes, as well as from existing cash and cash equivalents balances and cash flows provided by our operations. As of March 31, 2026, no funds remained available under the share repurchase program. Subsequent Event On April 15, 2026, the Board approved recommitting our existing share repurchase program so that $250,000 was available. The share repurchase program has no expiration date. Shares Reserved for Issuance As of March 31, 2026, we have reserved 4,905 shares in connection with our Stock Plans discussed in Note 11 of the Notes to Consolidated Financial Statements.
|